Literature DB >> 16622183

Rapid photoinactivation of native AMPA receptors on live cells using ANQX.

Pamela M England1.   

Abstract

AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors, a major subtype of ionotropic glutamate receptors, mediate the majority of fast excitatory synaptic transmission in the mammalian brain. The constitutive and regulated trafficking of AMPA receptors into and out of excitatory synapses ensures rapid responses to synaptically released glutamate and provides a mechanism for synaptic plasticity. To permit the direct, quantitative, real-time measurement of native AMPA receptor trafficking in live neurons, we designed and utilized a membrane-impermeable, photoreactive AMPA receptor antagonist to rapidly and irreversibly inactivate surface receptors with ultraviolet (UV) light. The photoreactive antagonist, 6-azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX), is an aryl azide that, when irradiated with UV light, becomes a highly reactive nitrene that can covalently cross-link to and thus irreversibly antagonize bound AMPA receptors. Thus, ANQX provides a means of rapidly silencing surface-exposed AMPA receptors. Combined with a functional AMPA receptor assay, such as continuous recording of AMPA receptor-mediated ionic currents, ANQX provides a means of directly monitoring native AMPA receptor trafficking in real time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622183     DOI: 10.1126/stke.3312006pl1

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  2 in total

Review 1.  AMPA receptors and synaptic plasticity: a chemist's perspective.

Authors:  James J Fleming; Pamela M England
Journal:  Nat Chem Biol       Date:  2010-02       Impact factor: 15.040

2.  6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.

Authors:  Leslie A Cruz; Eva Estébanez-Perpiñá; Sam Pfaff; Sabine Borngraeber; Ning Bao; Justin Blethrow; Robert J Fletterick; Pamela M England
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.